Personal Information
Unternehmen/Arbeitsplatz
Greater St. Louis Area United States
Beruf
Head of Research at Virta Health
Branche
Medical / Health Care / Pharmaceuticals
Webseite
www.linkedin.com/in/jamesmccarter
Info
James McCarter, MD, PhD
Dr. James McCarter is the Head of Research for San Francisco-based Virta Health, a tech-enabled nationwide medical provider that delivers the first clinically-proven treatment to safely and sustainably reverse type 2 diabetes without medications or surgery. He is also an Adjunct Professor of Genetics at Washington University (WU) School of Medicine in St. Louis and an Entrepreneur in Residence at the venture fund BioGenerator. He is an author of over 60 scientific publications and patents. Dr. McCarter is a recipient of the Innovation Award from the Academy of Science of St. Louis and a Crown Fellow of the Aspen Institute.
Tags
diabetes
nutritional ketosis
ketosis
virta health
nutrition
keto
telemedicine
cardiovascular disease
obesity
quantified self
insulin
low carb high fat
low carb
quantified stl
metabolic syndrome
beta-hydroxybutyrate
lchf
triglycerides
biohacking
washington university
biogenerator
diet
ketogenic
fitness
crossfit
apob
lipids
spine surgery
inflammation
digital health
chronic disease
biofeedback
type 2 diabetes
continuous remote care
scientific publishing
dyslipidemia
clinical trials
evidence-based medicine
behavioral medicine
virta
sugar
salt
muscle cramps
stamina
cholesterol
blood pressure
anti-inflammatory
glucose
clinical trial
neurolutions
ascension health ventures
eeg
brain computer interface
robotic glove
rehabilitation
stroke
healthy shopping list
stephen phinney
bohb
dexa scan
fitbit
liposcience
tim noakes
ronald krauss
jeff volek
plant-omega
algal dha
polyunsaturated fatty acid
vital omega-3 and 6 hufa test
pufa
hufa
omega 6
docosahexaenoic acid
eicosapentaenoic acid
epa
dha
omega 3
@monsantoco
@venturecafestl
@biogeneratorstl
@thebalsagroup
@wustldbbs
@idealabswustl
cortex
venture capital
entrepreneurship
biotechnology
nematology
saint louis
monsanto
arch grants
Mehr anzeigen
Präsentationen
(12)Dokumente
(3)Personal Information
Unternehmen/Arbeitsplatz
Greater St. Louis Area United States
Beruf
Head of Research at Virta Health
Branche
Medical / Health Care / Pharmaceuticals
Webseite
www.linkedin.com/in/jamesmccarter
Info
James McCarter, MD, PhD
Dr. James McCarter is the Head of Research for San Francisco-based Virta Health, a tech-enabled nationwide medical provider that delivers the first clinically-proven treatment to safely and sustainably reverse type 2 diabetes without medications or surgery. He is also an Adjunct Professor of Genetics at Washington University (WU) School of Medicine in St. Louis and an Entrepreneur in Residence at the venture fund BioGenerator. He is an author of over 60 scientific publications and patents. Dr. McCarter is a recipient of the Innovation Award from the Academy of Science of St. Louis and a Crown Fellow of the Aspen Institute.
Tags
diabetes
nutritional ketosis
ketosis
virta health
nutrition
keto
telemedicine
cardiovascular disease
obesity
quantified self
insulin
low carb high fat
low carb
quantified stl
metabolic syndrome
beta-hydroxybutyrate
lchf
triglycerides
biohacking
washington university
biogenerator
diet
ketogenic
fitness
crossfit
apob
lipids
spine surgery
inflammation
digital health
chronic disease
biofeedback
type 2 diabetes
continuous remote care
scientific publishing
dyslipidemia
clinical trials
evidence-based medicine
behavioral medicine
virta
sugar
salt
muscle cramps
stamina
cholesterol
blood pressure
anti-inflammatory
glucose
clinical trial
neurolutions
ascension health ventures
eeg
brain computer interface
robotic glove
rehabilitation
stroke
healthy shopping list
stephen phinney
bohb
dexa scan
fitbit
liposcience
tim noakes
ronald krauss
jeff volek
plant-omega
algal dha
polyunsaturated fatty acid
vital omega-3 and 6 hufa test
pufa
hufa
omega 6
docosahexaenoic acid
eicosapentaenoic acid
epa
dha
omega 3
@monsantoco
@venturecafestl
@biogeneratorstl
@thebalsagroup
@wustldbbs
@idealabswustl
cortex
venture capital
entrepreneurship
biotechnology
nematology
saint louis
monsanto
arch grants
Mehr anzeigen